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Abstract 
The aim of the current study is to reveal whether total funding and estimated valuation of startup 
firms can be associated with financial, human capital, and intellectual property domain 
measures. 96 startup firms representing healthcare sector were selected for multiple linear 
regression analysis. Average employee cost and number of patents are associated with funding 
and valuation in a range of 50-60% of variance explained. Funding and valuation normalized 
to total assets are associated with profitability and leverage measures in a range of 15-25% of 
variance explained. Associations are stronger for more mature firms and firms with intellectual 
property portfolios. 
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1. Introduction 
Rapid growth of technology leads to founding of numerous startup firms whose goal is to 
commercialize new inventions. Usually firm is considered to be a startup when it is managed 
by founders, it has not yet reached break-even, and they have fast growing business potential 
(Birley and Westhead 1994; Oe and Mitsuhashi 2013; Paternoster et al. 2014).  
Startup firms require continuous funding for product development and market entry. Those 
funds usually are acquired from FFF (founders, family, friends), BA (business angels), VC 
(venture capital), crowdfunding or bank loans. Depending on a growth phase of startup, one of 
these financing instruments are used. However, in all these cases it is important to value the 
company prior any investment. Although there are several methods for startup valuation 
reviewed and analyzed in the literature (Aydın 2015; Damodaran 2009; Festel, Wuermseher, 
and Cattaneo 2013), none of them are perfect and in certain cases final decision drivers remain 
unclear. Therefore, a posteriori analysis to find what measures associate with startup firm value 
and funding is useful. This is important for both, entrepreneurs and funders. From 
entrepreneurs’ perspective, knowing those key measures helps them to focus on those measures 
to improve their firm for higher valuation and better funding. From funders perspective, they 
need to foresee potential of future success and this can be based on present key measures. 
Healthcare sector is highly regulated and thus market entry barrier is high in comparison with 
other sectors. Therefore, startup firms active in the healthcare sector require substantial funding. 
However, the sector has an annual growth rate of 8.9% according to a recent market analysis 
(Wood 2019) and with clear global needs it is attractive for investments. Considering previously 
mentioned aspects, funding decisions and valuations in this sector are more rational and less 
driven by emotions. 
Objective of the study is to reveal whether total funding and estimated valuation of startup firms 
can be associated with financial, human capital, and intellectual property domain measures. 
Firms with known total funding and estimated valuations representing healthcare sector was 
selected. Further, information about their financial, human capital, and intellectual property 
domain measures were collected. Obtained data was analyzed with multivariate linear 
regression. 
The results indicate that financial domain measures, specifically profitability measure NI/TA 
are associated with both ratios, funding and valuation to total assets. Likewise, human and 
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intellectual property domain measures, specifically employee cost and number of patents are 
associated with both, funding and valuation. The associations between funding and valuation 
with given domains measures are similar in sign and magnitude. 
This article is structured as follows: (i) Literature overview that provides main related findings 
from relevant literature, (ii) Methods and Data that introduce used methodology and data 
collection with variables calculated based on it, (iii) Results and Analysis that provides 
regression models with descriptions, (iv) Discussion that explains study findings and relates it 
with literature, and (v) Conclusion that summarizes the work.  
 
2. Literature overview 
Startup firms are oriented for rapid growth. They constantly need funds for their development 
activities. Despite that funding source can be different, firms need to be ongoingly valued.  
The literature review focuses on the three domains provided in Figure 1 as most usually cited 
in the literature in conjunction with startup firm funding and valuation. 
 
Figure 1. Associated variables and domains. 
Internal finance is shown to be most prevalent among small firms in high-tech industries 
(Himmelberg and Petersen 1994). Startup firms can use credit lines (such as bank debt and term 
loans) to fund their development investments. Guney et al. study shows that there is a significant 
relationship between used credit lines and R&D investment and this effect is relatively stronger 
for small and younger firms (Guney, Karpuz, and Ozkan 2017). But importance of external 
finance such as private equity investments is growing over the years (Hirukawa and Ueda 2011; 
Ning, Wang, and Yu 2014). This growth is significantly higher in medical devices and 
biotechnology sectors (Greg Borenstein 2010). While startup firm funding sources can be 
different, mostly venture capital (VC) funding measures and drivers are analyzed in literature. 
Particularly, Marullo et al. modeled startup success with three domains (i) financial, (ii) human 
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capital, and (iii) intellectual property measures (Marullo et al. 2018). The same domains are 
used in current study and are discussed below.  
2.1. Domain of financial measures 
Barth et al. analyzed market value correlation with equity book values as financial health (Barth, 
Beaver, and Landsman 1998). They found that investors emphasize the importance of equity 
book value or net income as financial health measure and account them in valuation with 
positive contribution. Relevance of financial versus non-financial measures in valuation of VC 
backed firms were analyzed in literature (Sievers, Mokwa, and Keienburg 2013). Their results 
show that financial information (revenues, sales, general & administrative expenses, research 
and development expenses, and cash) is as important as non-financial information (team 
composition, CEO education, team experience, reference customers, and number of patents), 
explaining individually about 50% of variation in valuation. Cash and general & administrative 
financial measures show the strongest association with valuation in their study models. 
However, they also show that in combination of financial and non-financial measures they 
reached 64% of explained variation in valuation.  
Several approaches to measure firm’s health in perspective to predict bankruptcy have been 
proposed and analyzed (Charitou, Neophytou, and Charalambous 2004; Pindado, Rodrigues, 
and Rodrigues 2017; Platt and Platt 2002; Pompe and Bilderbeek 2005). Those authors propose 
various financial ratios that are generalized into four groups according to Laitinen: (i) 
Profitability, (ii) Liquidity, (iii) Solidity, and (iv) Other factors (Laitinen 1992). The importance 
of these ratio domains is concluded in rather recent study where normalization to total assets 
(i.e. having total assets in the ratio denominator) has been applied, for example EBIT/TA, 
NI/TA, WC/TA, NFA/TA, RE/TA or S/TA (Lukason, Laitinen, and Suvas 2016, pp. 1972). 
Besides the latter, often is used normalization to Current Liabilities (CL) or Total Debt (TD).  
Similarly, ratios to total assets are used in investment-cash flow sensitivities’ modeling. The 
basis of their study was to substitute Tobin’s Q with investment to total assets ratio and they 
show that cash flow, previous investments, and turnover are significantly positively associated 
with investment (D’Espallier, Vandemaele, and Peeters 2008). Therefore, the health of a 
particular firm among its financial measures is important for valuation and investment decision. 
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2.2. Domain of human capital measures 
Human capital (HC) is important to most firms and it usually improves performance (Hitt 
2001). Several components contribute to HC. For instance founder’s and workers’ education, 
age, experience, and skills are considered (Dimov 2017; Marullo et al. 2018; Rocha et al. 2019). 
Also, HC effect has been analyzed via labor (Lee 2019).  
Baum et al. used time series regression techniques to analyze pre-IPO financing revenue, R&D 
spending, and number of R&D employees of startup firms with independent variables 
representing alliance capital, intellectual capital (IC), and HC domains. They found in contrary 
that VCs’ funding decision is driven by their cognitive tendency to overemphasize HC in startup 
firm they invest (Baum and Silverman 2004). However, other authors have found that human 
and social capital are important for decision to fund (Bosma et al. 2004). Hormiga et al. showed 
that human capital is especially important for firms in their first stage of life (Hormiga, Batista-
Canino, and Sánchez-Medina 2011). In addition to HC, another study found three important 
factors, (i) experience of prior funding, (ii) founders’ ability to recruit executives, and (iii) 
founding teams with a doctoral degree to be important measures that increase the likelihood to 
be funded by VC (Hsu 2007). Relationship between HC, value creation, and employee reward 
have been analyzed in the literature (Massingham and Tam 2015). They found that employee 
capability has positive relationship with pay (wages, salary or compensation), hence employee 
cost. A recent study shows that the cost of the employees of the firm has significant positive 
association with its investment (Mulier, Schoors, and Merlevede 2016). Overall, all these works 
provide support that HC is one of the most important criteria for startup funding and valuation. 
2.3. Domain of intellectual property measures 
Recently, Comino et al. divided startup firm development and maturation into three stages: (i) 
investment stage, (ii) patenting stage, and (iii) payoff stage (Comino and Graziano 2015). Their 
basis to consider a firm as a true innovator is a number of patent applications. However, they 
assume that Patent and Trademark Office (PTO) is granting all applications otherwise the firm 
cannot be considered as a true innovator. Therefore, they also count PTO probability for 
investment decision in their analysis. The conclusion of their study is that patents play crucial 
information role between startups and external investors. Another study supports this by 
showing that startup firms with granted patents have raised higher amount of total investments 
than firms without patents (Mann and Sager 2007). The difference is significant for biotech 
firms, where the total investment median value for startups with patents is 32 million and 
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without patents is 5 million. Therefore, an explanatory variable representing firm’s patent 
portfolio as an intellectual property measure is important to consider in funding and valuation. 
However, they also noted that PTO have lowered their standard and thus number of granted 
“bad” patents is rising. 
Conti et al. found with their model that VCs value patents more than FFFs (founders, family, 
friends) and BAs (business angels) in startup firm financings (Conti, Thursby, and Rothaermel 
2013). This also is supported by Nanda et al. findings that startup firms with bigger patent 
portfolio get higher valuation in comparison to those that have lower number of patents (Nanda 
and Rhodes-Kropf 2013). Also, they pinpointed that citations on firm's patents also increases 
the valuation. Another recent work analyzed values of patents and patent portfolios 
(Gambardella, Harhoff, and Verspagen 2017). They also considered inventors, their age, their 
educational degree (hence HC), work months invested for inventions, R&D expenditures, and 
others. Based on collected data of firms over various EU countries they derived decision making 
model. They conclude that bigger number of patents or portfolios lead to a higher firm value 
and any additional patent is not decreasing previous patent values. This all suggests that higher 
number of patent applications, granted patents, and portfolios in general are important measures 
for firm valuation and for any investment decision. 
Greenberg analyzed 317 Israeli startup firms investments in 981 rounds where corresponding 
number of firms in life-science sector were 80 with 252 investment rounds (Greenberg 2013). 
In their study the patent applications and granted patents are analyzed separately, and their 
conclusion is that for valuations of early firms there is no significant difference whether patents 
are applications or granted. Their results also show that patents contribute 20% to valuation and 
patent value is 3.3 million USD in life-science sector. 
Papageorgiadis et al. calculated over 1998–2011 time series an international patent systems’ 
strengths based on three class components: (i) Property rights protection costs, (ii) Monitoring 
costs, and (iii) Servicing costs (Papageorgiadis, Cross, and Alexiou 2014). Their proposed 
International patent systems strength index scores showed highest value 9.5 for Denmark and 
Finland, where the lowest is 2.9 for Venezuela. Their scoring index can be useful for valuing 
patent portfolios in addition to number of patents. 
In summary, given domain’s measures in literature are associated with funding and valuation 
of firms. These discussed approaches and analyses are focused on different types of firms and 
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with different objectives. To the knowledge of the author there is no such work that uses 
discussed domains measures in combination to explore associations with funding and valuation 
of early or startup firms. 
 
3. Methods and data 
Workflow of current study consists of several steps. The first step is data collection where data 
from different sources is combined. The next step is data modification and transformation where 
variables are calculated and winsorized when necessary. Further steps are multiple linear 
regression with variable selection and analysis of obtained multiple linear models. Final step is 
an interpretation of results. General workflow of this study is given in Figure 1 and described 
in detail below. 
 
Figure 2. Study workflow. 
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(funding and
valuation)
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3.1. Data collection 
In November 2017 total funding and estimated valuation values of 463 European startup 
companies that are active in the healthcare sector were collected. Total funding accounts all 
known investments and awarded grants. Estimated valuation is calculated by the data platform 
based on known information. The data source was startup global funding & trading platform 
FunderBeam that refers CrunchBase which is known social media platform for startups. 
Although Crunchbase data is self-reported and not always claimed to be fully accurate, it has 
previously been used in research (Ter Wal et al. 2016). The data is covering total funding for 
the past 10 years. Estimated valuations span from 65 thousand euros to 723 million euros and 
total funding from 9 thousand to 537 million euros. Original values in dollars were transformed 
into euros based on UN Operational Rates of Exchange on the 1st of November 2017. 
Financial data of selected startup firms was extracted in October 2019 from Amadeus, Bureau 
Van Dijk database. Supposedly by that time all annual reports of 2016 are submitted in national 
authorities and are accessible in Amadeus. All the collected financial data represents the year 
2016 statements (or year before for growth measures) that in turn reflects a year before reported 
total funding and valuation. Corresponding derived variables are given in Table 1. 
Table 1. Financial variables used in this study 
Abb. Amadeus name 
TA Total assets th EUR 2016 
TA-1 Total assets th EUR 2015 
NI P/L for period [= Net Income] th EUR 2016 
OR Operating revenue (Turnover) th EUR 2016 
OR-1 Operating revenue (Turnover) th EUR 2015 
SF Shareholders’ funds th EUR 2016 
IA Intangible fixed assets th EUR 2016 
IA-1 Intangible fixed assets th EUR 2015 
NE Number of employees 2016 
EBIT Operating P/L [=EBIT] th EUR 2016 
EBIT-1 Operating P/L [=EBIT] th EUR 2015 
CE Costs of employees th EUR 2016 
Table combined by Author. 
Human capital data is based on annual report figures from Amadeus and are calculated as an 
average employee_cost, i.e. total cost of employees is divided by number of employees. 
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Intellectual property data such as number of patents and patent kind list was extracted from 
European Patent Office Espacenet database using tailored php script via Open Patent Services 
(OPS) API. Number of granted patents was derived from patent kind list where kind code B 
represents granted patent. Although kind code meaning may vary between different countries, 
in the USA and Europe code A and B means patent application and granted patent, respectively. 
These are also regions where mostly IP protection is used in the field of healthcare. 
In summary, after collecting data that excludes firms with missing values (incomplete financial 
statements), the database contains 96 startup firms for further analysis. 
3.2. Data modification and transformation 
Explained variables, total funding (Fund) and estimated valuation (Val) were logarithmically 
transformed as it is commonly used in literature (Greenberg 2013). In order to analyze 
associations with finance ratios, a modification was derived to reflect dependence to size. For 
that Fund and Val were divided with total assets. This approach is commonly used in financial 
health analyses (Charitou et al. 2004; Lukason et al. 2016).  
Further, explanatory variables were derived as they are used in literature. Particularly financial 
measures dependence to total assets or operating revenue reflecting profitability or leverage 
measures. Certain growth measures reflecting a difference between current and previous year 
are also applied. In addition, EBIT and OR measures were binarized to proxy the presence of 
(negative) cash flows.  IP measures were logarithmically transformed. All derived variables of 
this study are given in Table 2. There are 4 explained (dependent) and 14 explanatory 
(independent) variables, where the latter cover three groups: (i) financial, (ii) human capital 
(HC), and (iii) intellectual property (IP). 
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Table 2. Variables used in the study. 
Domain Name Formula Description 
Ex
pl
ai
ne
d 
 log(Fund) log	(𝐹𝑢𝑛𝑑𝑖𝑛𝑔) Logarithm of funding 
log(Val) log	(𝑉𝑎𝑙𝑢𝑎𝑡𝑖𝑜𝑛) Logarithm of valuation 
Fund/TA 𝐹𝑢𝑛𝑑𝑖𝑛𝑔 𝑇𝐴⁄  Size dependent funding ratio 
Val/TA 𝑉𝑎𝑙𝑢𝑎𝑡𝑖𝑜𝑛 𝑇𝐴⁄  Size dependent valuation ratio 
Ex
pl
an
at
or
y F
in
an
ci
al
 
EBIT/TA 𝐸𝐵𝐼𝑇 𝑇𝐴⁄  Profitability measure, ROA 
NI/TA 𝑁𝐼 𝑇𝐴⁄  Profitability measure 
E/TA 𝐸 𝑇𝐴⁄  Leverage measure 
OR/TA 𝑂𝑅 𝑇𝐴⁄  Efficiency measure, asset turnover 
EBIT/OR 𝐸𝐵𝐼𝑇 𝑂𝑅⁄  Profitability measure, profit margin 
OR_growth (𝑂𝑅:;<= − 𝑂𝑅:;<?) 𝑂𝑅:;<?⁄  Growth measure 
TA_growth (𝑇𝐴:;<= − 𝑇𝐴:;<?) 𝑇𝐴:;<?⁄  Growth measure 
IA_growth (𝐼𝐴:;<= − 𝐼𝐴:;<?) 𝐼𝐴:;<?⁄  Growth measure 
EBIT_growth (𝐸𝐵𝐼𝑇:;<= − 𝐸𝐵𝐼𝑇:;<?) 𝐸𝐵𝐼𝑇:;<?⁄  Growth measure 
b(EBIT) A0	𝑖𝑓	𝐸𝐵𝐼𝑇 < 01	𝑖𝑓	𝐸𝐵𝐼𝑇	 ≥ 0G Binary indicator variable, 0 
if negative, 1 if positive 
b(EBIT_growth)* A0	𝑖𝑓	𝐸𝐵𝐼𝑇_𝑔𝑟𝑜𝑤𝑡ℎ < 01	𝑖𝑓	𝐸𝐵𝐼𝑇_𝑔𝑟𝑜𝑤𝑡ℎ	 ≥ 0G 
b(OR) A0	𝑖𝑓	𝑂𝑅 = 01	𝑖𝑓	𝑂𝑅 > 0G Binary indicator variable, 0 if no revenue, 1 if positive 
H
C*
* 
employee_cost 𝐶𝐸 𝑛OPQRSTOO⁄  Average cost of one employee 
IP
**
* log(patent) log	(1 + 𝑛QVWOXW) Log of unique patent documents, IP measure 
log(Gpatent) log	(1 + 𝑛YZVXWO[	QVWOXW) Log of granted patents, IP measure 
Notes. * b(EBIT_growth) is indicating whether EBIT change between 2015 and 2016 is positive or negative, ** 
HC is an abbreviation of human capital, *** IP is an abbreviation of intellectual property. Table combined by 
Author. 
3.3. Multiple linear regression 
This study relies on the assumption that startup funding and valuation are associated in a linear 
manner with measures representing (i) financial, (ii) human capital, and (iii) intellectual 
property domains. For finding the associations among given variables multiple linear regression 
(MLR) was used, given in general form by Equation 1. 
𝑦 = 𝑓(𝑥<, 𝑥:, … , 𝑥`) + 𝜀    Equation 1. 
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Where y is the explained variable, x1,…,xK are the explanatory variables and e denotes 
unexplained variance. 
For MLR modeling SAS® University Edition software package was used. For variable 
selection a stepwise selection method with Schwarz Bayesian information criterion was used. 
It adjusts average check loss with degrees of freedom (taking into consideration number of 
observations and number of parameters including the intercept). This procedure is eliminating 
insignificant variables and avoids overfitting of models. Also highly intercorrelated variables 
were avoided in models. 
In some cases, when modeling reveals that variables need to be further transformed (for 
example, when creating a subset), it is necessary to go back to the data modification and 
transformation stage, as shown in the dashed line in Figure 2. 
Further, in analysis of MLR models regression coefficients (b) and its signs show magnitude 
and direction of corresponding variable association to explained variable. Percentages that are 
described by explanatory variable unique contribution into explained variable are described by 
squared semi-partial correlation coefficients (sr2). 
 
4. Results and Analysis 
In this study four explained variables are used that can be divided into two groups. First, 
logarithmically transformed total funding log(Fund) and estimated valuation log(Val) of startup 
firms. They represent a magnitude of investments and business potential. Second, the same total 
funding and valuation normalized to total assets, Fund/TA and Val/TA, respectively. They 
consider size dependency via normalization and represent efficiency of business potential. 
Association of financial, human capital, and intellectual property measures with funding and 
valuation are analyzed over the whole sample set that is representing a startup firms from 
healthcare sector. In addition, the association of the same variables among subsets where (i) the 
whole set is divided by the presence of intellectual property (patents) and (ii) divided into two 
groups by the age of firms were analyzed. 
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4.1. Analysis of the whole data set 
Four linear models were derived on the whole data set (Table 3). Particularly, log(Fund) and 
log(Val) models are describing 40% of their variance (Model 1 and Model 2). Relevant 
variables in those models are employee_cost and log(patent) representing human capital and 
intellectual property, associating uniquely 16% and 13% to log(Fund) variance, and 
correspondingly 18% and 11% to log(Val), and roughly 10% is shared contribution for both. 
Shared contribution is what remains after subtracting unique contributions from the total 
variance described.  Intercept and regression coefficients for both variables are positive. Thus, 
higher worth of team and bigger IP portfolio contribute to higher valuation end eventually to 
bigger funding. Regression coefficients of these explanatory variables are in the same range for 
both log(Fund) and log(Val) meaning that their association is similar. But the intercept for 
log(Val) is bigger than the intercept for log(Fund) meaning that valuations are about five times 
bigger than funding. For comparison, the median value of valuation is about four times bigger 
than median value of funding in the sample set. 
However, in both models about 60% of variance remains unexplained. This includes error as 
well as other parameters, such as social capital, market potential, and reputation as they are 
described in the literature  (Banerji and Reimer 2019; Hsu 2004; Petty and Gruber 2011; Yang 
and Berger 2017) but not used in current study. 
Among Fund/TA and Val/TA datasets were spotted 7 serious outliers that were removed from 
further analysis resulting with 89 cases for modeling. Again, similar two parameter models 
were derived for funding and valuation with EBIT/TA and E/TA as explanatory variables. 
Regression coefficients of them are both negative meaning that high profitability and leverage 
measures probably reduce a need for funding. Particularly, with positive efficiency (EBIT/TA) 
the investment into firm is less significant in terms of assets, or even firm can use its own profit 
for growth and do not need external funding. This makes an investment expensive for investor 
and thus less attractive. Thus, in contrary, negative efficiency shows better funding potential 
and market potential, and eventually strong business plan. Negative leverage measure E/TA 
shows accumulated loss. 
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Table 3. log(Fund) and log(Val) models over the entire sample set. 
W
ho
le
 se
t 
  b* p** sr2*** b p sr2 
  Model 1, log(Fund) Model 2, log(Val) 
Intercept 5.76 <.0001   6.47 <.0001   
employee_cost 9.29•10-06 <.0001 0.16 9.27•10-06 <.0001 0.18 
log(patent) 0.411 <.0001 0.13 0.360 <.0001 0.11 
n 96    96    
R2 0.40    0.40    
F value 31    31    
  Model 3, Fund/TA Model 4, Val/TA 
Intercept 1.83 <.0001   9.13 <.0001   
EBIT/TA -1.82 0.0006 0.10 -9.21 0.001 0.093 
E/TA -0.643 0.026 0.042 -3.74 0.014 0.051 
n 89    89    
R2 0.31    0.31    
F value 19    20    
Notes. * b is a regression coefficient, ** p is a p-value, *** sr2 is a squared semi-partial correlation. Table combined 
by Author. 
Intercept and regression coefficients are bigger for Val/TA model in absolute values. However, 
unique contribution by squared semi-partial correlation are similar for both models, about 10% 
and 5% for EBIT/TA and E/TA, respectively. This shows that association and contribution of 
these explanatory variables into Fund/TA and Val/TA are similar, but the magnitude is about 5 
times different. 
4.2. Analysis of subsets separated by presence of patent 
Some business models do not foresee patenting of inventions. They may rely on public domain 
inventions, licensed inventions or keeping inventions as a trade secret. Therefore, for further 
analysis two subsets for separate modeling were generated – one without and one with startup 
firms who have patents.  
Among firms without patents only employee_cost is associated with log(Fund) and log(Val) 
(Model 5 and Model 6 in Table 4). Association for log(Val) is stronger, covering 32% of 
variance while coverage for log(Fun) is 26%. The same explanatory variables as for the whole 
set (employee_cost and log(patent)) are associated with log(Fund) and log(Val), and additional 
binary variable bEBIT_growth for log(Fund) model (Model 9 and Model 10). Total variance 
described by these models are 62% and 51% for log(Fund) and log(Val), respectively. In this 
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subset log(patent) plays an important role contributing uniquely 30% of variance while the 
others, employee_cost and bEBIT_growth contribute uniquely 10% or less. Regression 
coefficients of log(patent) and employee_cost are positive and follow the same logic as 
described above. But bEBIT_growth regression coefficient is negative, and this can be 
explained by increase in startup firm burn rate which reflects its capability to be fast in product 
development. This also may mean that a startup firm has been successful to attract funding and 
is in growth phase. 
Table 4. Models of with/without patent divided subsets. 
  b p sr2 b p sr2 
W
ith
ou
t p
at
en
t  
 Model 5, log(Fund) Model 6, log(Val) 
Intercept 5.78 <.0001   6.46 <.0001   
employee_cost 1.10•10-05 0.0006  0.26 1.15•10-05 0.0001  0.32 
n 41     41     
R2 0.26     0.32     
F value 14     18     
  Model 7, Fund/TA Model 8, Val/TA 
Intercept 0.439 0.51   11.8 0.0003   
NI/TA -3.27 0.0015  0.27 -9.26 0.011  0.14 
bEBIT 1.68 0.059  0.086       
E/TA       -9.11 0.030  0.10 
n 35     35     
R2 0.28     0.37     
F value 6.2     9.5     
W
ith
 p
at
en
t 
  Model 9, log(Fund) Model 10, log(Val) 
Intercept 5.31 <.0001   5.9 <.0001   
bEBIT_growth -0.323 0.027  0.039       
employee_cost 6.27•10-06 0.0029  0.073 6.88•10-06 0.0016  0.10 
log_patent_ 0.902 <.0001  0.34 0.82 <.0001  0.32 
n 55     55     
R2 0.62     0.51     
F value 27.4     27.4     
  Model 11, Fund/TA Model 12, Val/TA 
Intercept 1.49 <.0001   7.08 0.0003   
EBIT/TA -1.96 <.0001  0.29 -10.58 <.0001  0.27 
n 54     54     
R2 0.29     0.27     
F value 21     19     
Notes. Table combined by Author. 
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Models in regard to funding and valuation ratios show slightly better results in terms of variance 
explained among without patent subset. Similarly, profitability and leverage measures are 
important. However, instead of EBIT/TA, NI/TA comes up to me more relevant. And in the 
case of Fund/TA (Model 7) E/TA is substituted with binary bEBIT categorizing firms into two 
classes, with negative and positive EBIT. Regression coefficient sign is positive meaning that 
positive EBIT is generally favored. However, unique contribution of bEBIT is less than 10% 
and statistical significance is slightly over 0.05, thus this association should be treated with 
caution. In a case of subset with patent only profitability ratio EBIT/TA is relevant covering 
about 30% of the variance in both cases, for Fund/TA and Val/TA (Model 11 and Model 12). 
4.3. Analysis of subsets separated by firm age 
Young startup firms are usually at a very early stage in their development. They usually are in 
(pre)seed investment phase where investment decisions are emotional, especially in a case of 
FFF (founders, family, friends). Therefore, the whole data set under current study were divided 
into two subsets where the first accounts startup firms up to five years old and the second 
accounts 6-10 years old ones. 
Among models based on younger firms (1-5 years old) subset employee_cost is associated with 
log(Fund) and log(Val) (Model 13 and Model 14 in Table 5). Results are very similar to models 
of without patent subset. Employee_cost association to log(Fund) and log(Val) covers 24% and 
28% of variance, respectively. 
Similarly to models based on with patent subset, for older firms (6-10 years old) subset 
log(patent) variable is additionally associated with both explained variables. However, 
EBIT/OR becomes also significant for log(Val) (Model 18). The sign of regression coefficient 
of given profit margin measure is negative, and this can be explained similarly to Model 9, i.e. 
it can be related firm’s burn rate. Association strength is here bigger, in total 45% and 56% of 
explained variance for log(Fund) and log(Val), respectively. The best explanatory variable is 
log(patent) showing slightly more than 20% of unique contribution.  
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Table 5. Models of subsets divided by firm age. 
  b p sr2 b p sr2 
1-
5 
ye
ar
s o
ld
 
 Model 13, log(Fund) Model 14, log(Val) 
Intercept 5.78 <.0001   6.48 <.0001   
employee_cost 1.26•10-05 0.001 0.240 1.28•10-05 0.0004 0.2814 
n 41     41     
R2 0.24     0.28     
F value 12.5     15.3     
  Model 15, Fund/TA Model 16, Val/TA 
Intercept 1.60 <.0001   8.05 0.0006   
NI/TA -1.31 0.04 0.11 -9.86 0.02 0.15 
n 36     36     
R2 0.11     0.15     
F value 4     6.04     
6-
10
 y
ea
rs
 o
ld
 
  Model 17, log(Fund) Model 18, log(Val) 
Intercept 5.80 <.0001   6.45 <.0001   
employee_cost 8.59•10-06 0.0002 0.18 6.55•10-06 0.0014 0.10 
log(patent) 0.438 <.0001 0.22 0.440 <.0001 0.24 
EBIT/OR       -0.0255 0.0105 0.061 
n 55     55     
R2 0.45     0.56     
F value 21     21     
  Model 19, Fund/TA Model 20, Val/TA 
Intercept 1.27 0.002   2.80 0.1772   
bEBIT_growth       5.73 0.0276 0.060 
NI/TA -3.01 <.0001 0.33 -15.81 <.0001 0.39 
n 53     53     
R2 0.33     0.42     
F value 25.6     18.1     
Notes. Table combined by Author. 
In respect to ratios reflecting financial domain NI/TA is significant for both subsets, younger 
and older firms. For younger firms it is associated with 11% and 15% of Fund/TA and Val/TA 
variation, respectively (Model 15 and Model 16 in Table 5). In turn, for Val/TA model binary 
bEBIT_growth becomes additionally relevant for older, 6-10 years old firms (Model 20). 
Regression coefficient sign of bEBIT_growth is positive, reflecting that profitability growth is 
favorable for valuation. However, covering just 6% of unique contribution, but in overall 
increasing roughly 10% of explained variance in comparison to Fund/TA. Here again, older 
firms are better explained in terms of explained variance due to more stable business model. 
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In overall, explanatory variables included in the study and in the models supplemented with 
their direction are given in Table 6. In the table association with explained variables are given 
in separate columns, one for whole set and four for subset models. Particularly 0 denotes no 
association, – and + denotes negative or positive association, respectively. For log(Fund) and 
log(Val) variables log(patent), employee_cost are important with positive association and 
binary b(EBIT_growth) with negative association. As expected, for Fund/TA and Val/TA are 
important other ratios, EBIT/TA, NI/TA, E/TA with negative association and b(EBIT) with 
positive association. Other used explanatory variables OR/TA, NI/TA, E/TA, OR_growth, 
TA_growth, IA_growth, b(OR), and log(Gpatent) have no significant association in the 
compiled models. In the whole data set there are only 11 startup firms that have granted patents 
and thus log(Gpatent) is not significant as it is often described in literature (Festel et al. 2013; 
Mann and Sager 2007; Marullo et al. 2018). 
Table 6. Association of explanatory variables. 
  
  
log(Fund) log(Val) Fund/TA Val/TA 
whole* subsets** whole subsets whole subsets whole subsets 
EBIT/TA 0 0000 0 0000 – 0–00 – 0–00 
NI/TA 0 0000 0 0000 0 –0–– 0 –0–– 
E/TA 0 0000 0 0000 – 0000 – –000 
OR/TA 0 0000 0 0000 0 0000 0 0000 
EBIT/OR 0 0000 0 000– 0 0000 0 0000 
OR_growth 0 0000 0 0000 0 0000 0 0000 
TA_growth 0 0000 0 0000 0 0000 0 0000 
IA_growth 0 0000 0 0000 0 0000 0 0000 
b(EBIT) 0 0000 0 0000 0 +000 0 0000 
b(OR) 0 0000 0 0000 0 0000 0 0000 
b(EBIT_growth) 0 0–00 0 0000 0 0000 0 000+ 
employee_cost + ++++ + ++++ 0 0000 0 0000 
log(patent) + 0+0+ + 0+0+ 0 0000 0 0000 
log(Gpatent) 0 0000 0 0000 0 0000 0 0000 
Notes. * the whole data set (96 firms), ** subsets in following order: without patent subset (41 firms), with patent 
subset (55 firms), 1-5 years old firms subset (41 firms), 6-10 years old firms subset (55 firms), and where 0 is no 
association, – is negative association, + is positive association. Table combined by Author. 
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5. Discussion 
Results of the study show that log(Fund) and log(Val) are associated with employee_cost and 
log(patent) among selected variables (Table 6). Employee_cost can be related to firm’s average 
team value accounting for both, development and management teams. The use of employee 
cost in such context is rather new to the author’s knowledge. It reflects human capital domain 
that is found to be important in previous studies as well (Baum and Silverman 2004; Bosma et 
al. 2004; Hsu 2007). Log(patent) on another hand is describing a strength of firm’s technology 
and reflects intellectual property domain. An importance of patents, especially granted patents, 
is also reported in literature by other authors (Marullo et al. 2018).  
When considering models compiled for log(Fund) and log(Val) in subsets, additionally EBIT 
related variables are significant with negative association for log(Val). This can be explained 
by higher burn rate which is due to intense product or service development and refers to 
significant prior funding based on good business plan and market potential. 
Looking at startup firms by age and patents, it can be concluded that the age of a startup firm 
does not indicate the stage of its development. Particularly, in the current data set there are 18 
firms that have patents but they are 5 or less years old, and at the same time there are 18 firms 
that do not have patents but are 6 to 10 years old. Nonetheless, models for age and patent subsets 
show similar associations, although the quality of the models is lower for younger and without 
patent firms, covering roughly 25-30% of variance for both, log(Fund) and log(Val). The lack 
to describe younger and early stage firms is a clear limitation of this study. For better results, 
variables that are describing entrepreneurial capability, social capital, market potential, and 
reputation could be added as it is described in the literature and are considered important 
especially on early stage funding decisions made by FFFs (founders, family, friends) and BAs 
(business angels) (Banerji and Reimer 2019; Hsu 2004; Petty and Gruber 2011; Yang and 
Berger 2017).  
However, models on firms that are older or with more developed technology (patent exists) are 
showing moderately better associations, covering roughly 50-60% of variance for both, 
log(Fund) and log(Val). The most important variable in those models is log(patent) contributing 
uniquely 20-30%. This increased strength of associations can be explained by the fact that older 
and technology-rich firms have significantly higher valuations (and correspondingly funding) 
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and are made by VCs. This is supported also by literature where is concluded, that VCs value 
patents more than FFFs and BAs (Conti et al. 2013). 
Funding and valuation ratio to total assets models mostly show association with profitability 
measure, either EBIT/TA or NI/A supplemented few times by binary bEBIT or binary 
bEBIT_growth with slight contribution. Despite lower quality of models in terms of variance 
explained, certain explanations can be given. Particularly, profitability measure’s regression 
coefficient has a negative sign in all these models, meaning that generally profitability is not 
preferred. This is in accordance with general rule of venture capitalists who are seeking an 
investment opportunity into high growth potential business plans and with a clear focus on 
product development. They consider other sales as distraction. On the other hand, if a startup 
firm already generates sales, they may not need any more substantial investment and can 
bootstrap their growth. 
 
6. Conclusion 
This study focused on explaining total funding and estimated valuation of healthcare sector 
startup firms through financial, human capital, and intellectual property domain measures. For 
explained variables logarithmical transformation and normalization to total assets was used. All 
together there are four explained and fourteen explanatory variables among 96 startup firms. 
Multiple linear regression analysis revealed that human capital and intellectual property 
measures are positively associated with funding and valuation covering 40-50% of total 
variance. For more mature firms, additionally EBIT related financial measures are negatively 
associated with funding and valuation. However, the association of EBIT related financial 
measures are weaker than others, adding less than 10% to explained variance.  
On the other hand, if total funding and estimated valuation is normalized to total assets then 
only financial measures can be associated. Particularly, profitability measures are negatively 
associated covering roughly 10-25% of variance explained. Additionally, leverage measures 
are also negatively associated covering approximately 5% of variance explained for both 
explained ratio variables, normalized finding and valuation. The negative association is 
explained by general rule of venture capitalists who are seeking an investment opportunity into 
high growth potential business plans and with a clear focus on product development. There is 
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also a positive association of binary EBIT and binary EBIT growth measures covering 
approximately 5% of variance explained. These explanatory variables are fitting those startup 
firms in the sample set that are bootstrapping their growth. 
Startup firms that are older and have patent portfolio show better association with financial, 
human capital, and intellectual property domain measures in terms of explained variance. This 
is related to more stable stage of firms and tendency to attract venture capital investments where 
the decision to invest is more rational than in case of founder-family-friends and business angel 
investments. 
Overall, the main finding of this study is that using logarithmically transformed funding and 
valuation values show clear association with human capital and intellectual property domain 
measures. Association with financial domain measures is rather weak. On another hand, 
funding and valuation to total assets ratios are more associated with financial domain measures 
and not with human capital and intellectual property measures. However, the association is 
generally weaker with ratio type explained variables than with logarithmically transformed 
variables. The association between funding and valuation with financial, human capital, and 
intellectual property domain measures is very similar in both cases. 
Limitations of the current study are that the sample set used is rather small because of absent 
data, particularly incomplete financial statements. Also, the sample set consists of startup firms 
in different growth phases. This gives a bigger effect on an individual value and may skew 
regressions. In addition, the study does not account social capital domain measures that are 
often reported in literature to be significant and well human capital domain could be elaborated 
more widely. The latter aspects should be considered for future work. 
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